Simplex Trading, LLC Nektar Therapeutics Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Simplex Trading, LLC holds 6,988 shares of NKTR stock, worth $7,477. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,988

Previous 2,251 210.44%

Holding current value

$7,477

Previous $2,000 350.0%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$1.11 - $1.48 $5,258 - $7,010	4,737 Added 210.44%	6,988 $9,000
Q2 2024 Jul 25, 2024	BUY	$0.9 - $1.83 $2,025 - $4,119	2,251 New	2,251 $2,000
Q4 2023 Feb 02, 2024	SELL	$0.42 - $0.57 $2,858 - $3,879	-6,806 Reduced 64.06%	3,819 $2,000
Q3 2023 Nov 01, 2023	BUY	$0.51 - $1.05 $1,792 - $3,690	3,515 Added 49.44%	10,625 $6,000
Q2 2023 Aug 04, 2023	BUY	$0.53 - $1.03 $1,138 - $2,213	2,149 Added 43.32%	7,110 $4,000
Q1 2023 Apr 27, 2023	SELL	$0.64 - $3.15 $743 - $3,660	-1,162 Reduced 18.98%	4,961 $3,000
Q4 2022 Feb 02, 2023	SELL	$2.03 - $4.28 $26,757 - $56,414	-13,181 Reduced 68.28%	6,123 $13,000
Q3 2022 Nov 04, 2022	BUY	$3.04 - $5.14 $14,008 - $23,685	4,608 Added 31.36%	19,304 $61,000
Q2 2022 Aug 03, 2022	SELL	$3.17 - $6.17 $13,326 - $25,938	-4,204 Reduced 22.24%	14,696 $55,000
Q1 2022 May 02, 2022	BUY	$4.16 - $13.72 $54,733 - $180,514	13,157 Added 229.1%	18,900 $101,000
Q3 2021 Oct 28, 2021	SELL	$13.07 - $18.84 $10,456 - $15,072	-800 Reduced 12.23%	5,743 $100,000
Q2 2021 Aug 12, 2021	BUY	$16.52 - $20.4 $13,810 - $17,054	836 Added 14.65%	6,543 $112,000
Q1 2021 Apr 26, 2021	BUY	$16.56 - $25.46 $10,879 - $16,727	657 Added 13.01%	5,707 $114,000
Q4 2020 Feb 02, 2021	SELL	$15.77 - $19.03 $362,173 - $437,042	-22,966 Reduced 81.97%	5,050 $85,000
Q3 2020 Oct 14, 2020	SELL	$16.59 - $24.79 $41,541 - $62,074	-2,504 Reduced 8.2%	28,016 $464,000
Q2 2020 Jul 13, 2020	SELL	$16.86 - $23.44 $120,498 - $167,525	-7,147 Reduced 18.97%	30,520 $706,000
Q1 2020 Apr 29, 2020	SELL	$14.47 - $27.96 $626,796 - $1.21 Million	-43,317 Reduced 53.49%	37,667 $672,000
Q4 2019 Feb 05, 2020	BUY	$15.87 - $23.12 $511,521 - $745,203	32,232 Added 66.11%	80,984 $1.75 Million
Q3 2019 Oct 15, 2019	BUY	$16.91 - $36.27 $665,966 - $1.43 Million	39,383 Added 420.35%	48,752 $888,000
Q2 2019 Jul 26, 2019	SELL	$31.0 - $36.3 $427,862 - $501,012	-13,802 Reduced 59.57%	9,369 $333,000
Q1 2019 Apr 18, 2019	BUY	$31.58 - $46.35 $306,073 - $449,224	9,692 Added 71.9%	23,171 $0
Q4 2018 Jan 16, 2019	SELL	$30.43 - $56.65 $485,875 - $904,530	-15,967 Reduced 54.22%	13,479 $443,000
Q3 2018 Oct 23, 2018	SELL	$46.46 - $68.49 $159,868 - $235,674	-3,441 Reduced 10.46%	29,446 $1.8 Million
Q2 2018 Jul 30, 2018	BUY	$46.25 - $104.45 $699,670 - $1.58 Million	15,128 Added 85.18%	32,887 $1.61 Million
Q1 2018 Apr 26, 2018	BUY	$57.4 - $108.44 $1.02 Million - $1.93 Million	17,759 New	17,759 $1.89 Million
Q4 2017 Jan 10, 2018	SELL	$23.02 - $60.5 $712,791 - $1.87 Million	-30,964 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$17.79 - $24.0 $550,849 - $743,136	30,964	30,964 $743,000

Others Institutions Holding NKTR

# of Institutions

147

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $201M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Nektar Therapeutics Transaction History